Diagnosis and Treatment Planning Services
Ga68 PSMA PET/CT
68Ga-PSMA PET/CT is an innovative theranostic nuclear medicine imaging technique that plays a major role in detecting and imaging prostate cancer. Scientific studies have shown that this method is far superior and sensitive in detecting prostate cancer than traditional imaging methods such as CT or whole body bone scan.
F18 NaF PET/CT
F18 NaF PET / CT Procedure
Prostate cancer bone metastases can be monitored with high sensitivity with Fluorine-18-NaF (18F-NaF) PET / CT. Your physician may recommend this test for the diagnosis of bone metastases. 18F-NaF PET / CT; While accurately showing the location and extent of bone metastases, it also enables the use of Radium-223 therapy, a successful targeted treatment option for painful bone metastases.
Ga68 DOTA-TATE PET/CT
68Ga-DOTA-TATE is an innovative theranostic nuclear medicine imaging technique that plays an important role in the detection and imaging of neuroendocrine tumors. Neuroendocrine tumors; They are rare cancers that can occur anywhere in the body, often in the intestine, pancreas and lungs.
I-131 Total Body Scan
I-131 Whole Body Scanning Scintigraphy Procedure
In order to diagnose thyroid cancer, low dose radioactive iodine (131I) can be used to visualize tumoral tissues with high sensitivity and specificity.
Tc-99m MMA Liver Perfusion Scan
Tc-99m MAA Liver Perfusion Scintigraphy Procedure
In liver cancers, leaks to the lung and gastrointestinal system can be detected with high sensitivity with 99mTc-MAA liver perfusion scintigraphy performed for pre-treatment rehearsal and the optimum treatment dose can be planned.
Lutetium-177 PSMA Therapy
Lutetium-177 PSMA therapy is an innovative and effective treatment that is increasingly used to treat metastatic castration-resistant prostate cancer. Generally, it is used with the recommendation of the follow-up doctor when other approved methods are exhausted, shown to be ineffective, or patients cannot tolerate them. This treatment; It helps to reduce tumor size and prevent tumor proliferation, as well as reduce the signs and symptoms caused by the tumor.
Radium-223 treatment is a type of treatment used in patients with prostate cancer that has metastasized (spread) to the bones, with the recommendation of the following physicians. Its purpose is to damage cancer cells in the bone, causing the tumors to shrink or even disappear completely. It is also used to reduce cancer-related pain in the bones.
Lutetium-177 DOTA-TATE Therapy
Lutetium-177 DOTA-TATE; It is a treatment method used in neuroendocrine tumors. It is also known as “targeted radionuclide therapy”, “peptide receptor radionuclide therapy (PRRT)” “somatostatin receptor radioligand therapy.
Radioactive Iodine Treatment
Radioactive iodine therapy is a standard practice that has been frequently preferred in the treatment of benign and malignant (cancer) diseases of the thyroid since the 1940’s and has been shown to have an effect on survival in patients with thyroid cancer. Specific and targeted treatment of tumoral tissues can be performed with high dose radioactive iodine 131I.
Yttrium-90 Microsphere Therapy
With yttrium-90 (90Y) microsphere treatment, targeted treatment of tumoral tissues detected by 99mTc-MAA liver perfusion scintigraphy can be performed. It is a very successful and new method for theranostic applications.
Why MNT is different?
We carried our experience and expertise in nuclear medicine and radiation oncology into the field of theranostics. We aim to provide cancer patients with access to theranostic diagnosis and treatment methods with an optimum quality-cost balance. In the world, we successfully implement all of the methods to JCI accredited health institutions